What execs and experts think of the future of drug costs.
The deal is now official, but the companies have been acting as one for some time.
After last year’s drawn-out flu season, the CDC weighs in on what to expect in 2019-2020
At the 2019 Asembia Specialty Pharmacy Summit, former FDA Commissioner Scott Gottlieb discussed advances within the agency during his tenure.
Specialty pharmacy has reached an “inflection point” with the power to change the entire industry model.
With so many new immunotherapy treatments on the horizon, pharmacists need to understand the ins and outs of immuno-oncology biomarkers to best serve their patients.